A new clinical standard for cellular health
Niagen Plus is available exclusively through licensed healthcare professionals at 1200+ premium clinics nationwide and through the NiagenĀ® At-Home Telehealth program.
Every format is manufactured at FDA-compliant cGMP facilities and prescribed or administered under clinical supervision.
Published clinical data from a real-world setting
A peer-reviewed, retrospective pilot study compared commercially administered NAD+ IV and Niagenā¢ NR IV across four consecutive infusions. Niagen IV averaged 37 minutes per session versus 97 minutes for NAD+ IV, with markedly fewer adverse experiences and no clinically significant changes in blood chemistry or inflammatory markers at 30 days post-infusion.
Reyna et al., 2026. Frontiers in Aging.
The first controlled clinical study on Niagenā¢ IV
In a randomized, double-blind, placebo-controlled pilot study, a single 500mg infusion of Niagenā¢ IV produced a more than 20% peak increase in blood NAD+ levels at 3 hours post-infusion, with 75% less infusion time compared to NAD+ IV and fewer adverse experiences reported.
Hawkins et al., 2024. Preprint, medRxiv.
- NiagenĀ® At-Home Injection Kit is only available if prescribed after an online consultation with a healthcare provider. The statements on this page have not been evaluated by the FDA. Results may vary. If you notice any side effects while using this product, contact your healthcare provider immediately.
- Niagen Bioscience is not the manufacturer or compounder of this product. Compounding is performed by a licensed 503B outsourcing facility.
- Prescription NiagenĀ® may not be appropriate for everyone. A licensed clinician will review your health information during a telehealth consultation to determine eligibility.
- Ships from a licensed 503A pharmacy. Currently not available to ship to Alabama, Arkansas, and California.
